The purpose of QA (GxP) Director QA Evaluation and Integration is to lead the end-to-end Evaluation of “In-licensing (BD&L)” and “Merger/ Acquisition (M&A)” up to the Integration of the acquired or in-licensed asset into the Novartis network. In this role, you will facilitate timely decision making by QA Management including relevant line functions based on recommendation from QA SMEs and business evaluation for the holistic QA assessment covering the due diligence (DD) evaluation as well as the QA integration activities for potential external opportunities.